Interpace Biosciences Interpace Biosciences Q2 Revenues More Than Double The company attributed the higher revenues to increased reimbursement rates and greater clinical services volume for its cancer tests. Interpace Biosciences Q1 Revenues Up 8 Percent The company attributed the revenue increase to improved performance in its clinical services business and increased reimbursement rates for its cancer tests. Interpace Biosciences to Review Strategic Alternatives The company, which was recently delisted from the Nasdaq, began a reorganization earlier this year in order to cut $7.2 million in annual costs. Interpace Biosciences Q4 Revenues More Than Double The company said that it is on track to meet its goal of shaving $7.2 million in costs this year as it undertakes a recently announced restructuring plan. Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing. Feb 1, 2021 Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker Jan 20, 2021 Interpace Bio Q3 Revenues Rise 6 Percent Oct 20, 2020 Interpace Biosciences Q2 Revenues Decline 14 Percent Jun 26, 2020 Interpace Biosciences Q1 Revenues Rise 53 Percent Apr 23, 2020 Interpace Biosciences Q4 2019 Revenues Drop 29 Percent, Miss Analyst Predictions Jan 13, 2020 Interpace Biosciences to Sell $20M in Preferred Stock, Plans Reverse Stock Split Jan 6, 2020 Interpace Biosciences, University of North Carolina Launch Barrett's Esophagus Study Dec 20, 2019 Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change Premium Nov 13, 2019 Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences Oct 25, 2019 Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace Oct 17, 2019 Interpace Diagnostics Closes $13M Financing Investment Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 16, 2019 Interpace Diagnostics, Genecast Biotechnology Ink Worldwide Research Services Agreement Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 31, 2019 Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan Jul 29, 2019 Interpace Diagnostics Thyroid Assays Covered In-Network by Blue Shield of California Jul 22, 2019 Interpace Diagnostics, SelectHealth Sign Coverage Agreement for Thyroid Cancer Tests Jul 18, 2019 Helomics Inks Separate Pacts With UPMC, Interpace Dx for AI-Driven Oncology Decision Making Jul 15, 2019 Interpace Dx Acquires Cancer Genetics' Biopharma Services Jun 20, 2019 Interpace Diagnostics Thyroid Assays Covered by Independence Blue Cross Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.